Liontrust Investment Partners LLP Takes $518,000 Position in UFP Technologies, Inc. $UFPT

Key Points

• Liontrust Investment Partners LLP has acquired a new stake in UFP Technologies, buying 2,567 shares valued at approximately $518,000.
• UFP Technologies recently reported a quarterly earnings of $2.50 EPS, exceeding estimates and showing a revenue growth of 37.2% compared to the previous year.
• Lake Street Capital has raised its price target for UFP Technologies from $252.00 to $289.00, maintaining a "buy" rating for the stock.

Liontrust Investment Partners LLP acquired a new position in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,567 shares of the industrial products company's stock, valued at approximately $518,000.

Other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its position in UFP Technologies by 4.8% during the 4th quarter. JPMorgan Chase & Co. now owns 11,573 shares of the industrial products company's stock worth $2,830,000 after acquiring an additional 525 shares during the period. Wells Fargo & Company MN raised its stake in shares of UFP Technologies by 24.4% during the fourth quarter. Wells Fargo & Company MN now owns 8,312 shares of the industrial products company's stock worth $2,032,000 after purchasing an additional 1,629 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of UFP Technologies by 60.7% during the fourth quarter. Envestnet Asset Management Inc. now owns 20,812 shares of the industrial products company's stock worth $5,089,000 after purchasing an additional 7,865 shares during the period. Legal & General Group Plc grew its position in UFP Technologies by 3.6% in the 4th quarter. Legal & General Group Plc now owns 20,811 shares of the industrial products company's stock valued at $5,088,000 after buying an additional 717 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in UFP Technologies in the 4th quarter valued at $16,808,000. Institutional investors and hedge funds own 87.28% of the company's stock.

Wall Street Analyst Weigh In

Separately, Lake Street Capital lifted their price objective on UFP Technologies from $252.00 to $289.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $289.00.

UFP Technologies Stock Performance

Shares of NASDAQ:UFPT traded down $0.2850 during trading on Thursday, reaching $219.1050. 71,201 shares of the company's stock traded hands, compared to its average volume of 135,812. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.77 and a quick ratio of 1.53. The stock has a market capitalization of $1.69 billion, a P/E ratio of 25.27 and a beta of 1.14. UFP Technologies, Inc. has a 12 month low of $178.26 and a 12 month high of $366.41. The company has a 50 day moving average of $234.38 and a 200-day moving average of $229.16.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The industrial products company reported $2.50 earnings per share for the quarter, topping analysts' consensus estimates of $2.25 by $0.25. UFP Technologies had a net margin of 11.40% and a return on equity of 21.54%. The business had revenue of $151.18 million for the quarter, compared to analysts' expectations of $151.55 million. During the same quarter last year, the company earned $1.86 EPS. The company's revenue for the quarter was up 37.2% compared to the same quarter last year.

UFP Technologies Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.